Characterization of a Novel Pathogenic PLCG2 Variant Leading to APLAID Syndrome Responsive to a TNF Inhibitor.
Yang Z, Tao P, Han X, Kozlova A, He T, Volchkov E, Nesterenko Z, Pershin D, Raykina E, Fatkhudinov T, Korobeynikova A, Aksentijevich I, Yang J, Shcherbina A, Zhou Q, Yu X.
Yang Z, et al. Among authors: kozlova a.
Arthritis Rheumatol. 2024 Nov;76(11):1670-1678. doi: 10.1002/art.42948. Epub 2024 Aug 6.
Arthritis Rheumatol. 2024.
PMID: 38965708